CING
Price
$3.77
Change
+$0.07 (+1.89%)
Updated
Sep 4, 04:59 PM (EDT)
Capitalization
20.03M
SNBIF
Price
$16.45
Change
+$2.17 (+15.20%)
Updated
Aug 6 closing price
Capitalization
1.18B
Interact to see
Advertisement

CING vs SNBIF

Header iconCING vs SNBIF Comparison
Open Charts CING vs SNBIFBanner chart's image
Cingulate
Price$3.77
Change+$0.07 (+1.89%)
Volume$1.14K
Capitalization20.03M
Sanbio
Price$16.45
Change+$2.17 (+15.20%)
Volume$500
Capitalization1.18B
CING vs SNBIF Comparison Chart in %
Loading...
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CING vs. SNBIF commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CING is a Buy and SNBIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (CING: $3.70 vs. SNBIF: $16.45)
Brand notoriety: CING and SNBIF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CING: 126% vs. SNBIF: 111%
Market capitalization -- CING: $20.03M vs. SNBIF: $1.18B
CING [@Biotechnology] is valued at $20.03M. SNBIF’s [@Biotechnology] market capitalization is $1.18B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CING’s FA Score shows that 0 FA rating(s) are green whileSNBIF’s FA Score has 0 green FA rating(s).

  • CING’s FA Score: 0 green, 5 red.
  • SNBIF’s FA Score: 0 green, 5 red.
According to our system of comparison, both CING and SNBIF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CING’s TA Score shows that 4 TA indicator(s) are bullish while SNBIF’s TA Score has 1 bullish TA indicator(s).

  • CING’s TA Score: 4 bullish, 6 bearish.
  • SNBIF’s TA Score: 1 bullish, 1 bearish.
According to our system of comparison, SNBIF is a better buy in the short-term than CING.

Price Growth

CING (@Biotechnology) experienced а -11.48% price change this week, while SNBIF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.28%. For the same industry, the average monthly price growth was +7.11%, and the average quarterly price growth was +29.28%.

Industries' Descriptions

@Biotechnology (+0.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNBIF($1.18B) has a higher market cap than CING($20M). SNBIF YTD gains are higher at: 253.763 vs. CING (-24.949). CING has higher annual earnings (EBITDA): -15.75M vs. SNBIF (-2.99B). SNBIF has more cash in the bank: 3.96B vs. CING (9.52M). CING has less debt than SNBIF: CING (5.08M) vs SNBIF (598M). CING (0) and SNBIF (0) have equivalent revenues.
CINGSNBIFCING / SNBIF
Capitalization20M1.18B2%
EBITDA-15.75M-2.99B1%
Gain YTD-24.949253.763-10%
P/E Ratio0.03N/A-
Revenue00-
Total Cash9.52M3.96B0%
Total Debt5.08M598M1%
FUNDAMENTALS RATINGS
SNBIF: Fundamental Ratings
SNBIF
OUTLOOK RATING
1..100
46
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
86
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
65
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CINGSNBIF
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
29%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
14%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
14%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
8%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTYX2.590.13
+5.28%
Ventyx Biosciences
GOVX0.750.01
+0.92%
GeoVax Labs
DAVA14.380.04
+0.28%
Endava plc
PHI19.29-0.26
-1.33%
PLDT
ZS270.58-3.99
-1.45%
Zscaler

CING and

Correlation & Price change

A.I.dvisor tells us that CING and BEIGF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CING and BEIGF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CING
1D Price
Change %
CING100%
-0.80%
BEIGF - CING
29%
Poorly correlated
N/A
ELVN - CING
29%
Poorly correlated
+0.29%
SLNO - CING
28%
Poorly correlated
-0.48%
SNBIF - CING
28%
Poorly correlated
N/A
LQDA - CING
26%
Poorly correlated
+2.31%
More

SNBIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNBIF has been loosely correlated with HRMY. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SNBIF jumps, then HRMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNBIF
1D Price
Change %
SNBIF100%
N/A
HRMY - SNBIF
52%
Loosely correlated
+1.21%
QRON - SNBIF
34%
Loosely correlated
N/A
CING - SNBIF
28%
Poorly correlated
-0.80%
WXXWY - SNBIF
28%
Poorly correlated
+3.30%
EDSA - SNBIF
25%
Poorly correlated
+2.73%
More